Evidence map›Paper›PMID 30397167›Full record

ArticlePediatrics2018

Tobacco Product Harm Perceptions and New Use.

Maria A Parker, Andrea C Villanti, Amanda J Quisenberry, Cassandra A Stanton, Nathan J Doogan, Ryan Redner, Diann E Gaalema, Allison N Kurti, Tyler Nighbor, Megan E Roberts and 2 more

Open access · bronzeAbstract readMulticenter StudyVideo-Audio Media
In one paragraph

Article in Pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Effects of a Reduced Risk Claim on Adolescents' Smokeless Tobacco Perceptions and Willingness to Use.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Maria A ParkerTobacco Center on Regulatory Science, University of Vermont, Burlington, Vermont; maria.parker@uvm.edu.
Andrea C VillantiTobacco Center on Regulatory Science, University of Vermont, Burlington, Vermont.
Amanda J QuisenberryCenter of Excellence in Regulatory Tobacco Science, The Ohio State University, Columbus, Ohio.
Cassandra A StantonCenter for Evaluation and Coordination of Training and Research in Tobacco Regulatory Science, Westat, Rockville, Maryland.
Nathan J DooganCenter of Excellence in Regulatory Tobacco Science, The Ohio State University, Columbus, Ohio.
Ryan RednerRehabilitation Institute, Southern Illinois University, Carbondale, Illinois.
Diann E GaalemaTobacco Center on Regulatory Science, University of Vermont, Burlington, Vermont.
Allison N KurtiTobacco Center on Regulatory Science, University of Vermont, Burlington, Vermont.
Tyler NighborTobacco Center on Regulatory Science, University of Vermont, Burlington, Vermont.
Megan E RobertsCenter of Excellence in Regulatory Tobacco Science, The Ohio State University, Columbus, Ohio.
Antonio Cepeda-BenitoTobacco Center on Regulatory Science, University of Vermont, Burlington, Vermont.
Stephen T HigginsTobacco Center on Regulatory Science, University of Vermont, Burlington, Vermont.
University of Vermont · USThe Ohio State University · USGeorgetown University · USSouthern Illinois University Carbondale · US

Funding

Leadership and Logistics CoreU54DA046060 · NIDA · WESTAT, INC. · PI Robin J. Mermelstein, CASSANDRA A STANTON · 2018 to 2026
$28.1M
Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SIGMON, STACEY C · 2013 to 2022
$21.3M
University of Vermont Tobacco Center of Regulatory ScienceU54DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2018 to 2022
$19.4M
Vermont Center on Tobacco Regulatory ScienceP50DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2017
$19.1M
Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
Leadership and Administrative Core (p 188-304)U54CA189222 · NCI · WESTAT, INC. · PI NIAURA, RAYMOND, ROSENTHAL, JEANNE · 2014 to 2018
$8.5M
TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
NCI NIH HHS P50 CA180908NCI NIH HHS U54 CA189222NIDA NIH HHS P50 DA036114NIDA NIH HHS T32 DA007242NIDA NIH HHS U54 DA036114NIDA NIH HHS U54 DA046060NIGMS NIH HHS P20 GM103644
6 · The paper itself

Abstract

: media-1vid110.1542/5839992833001PEDS-VA_2018-1505

methodsProduct-specific absolute and relative harm perceptions for cigarettes, electronic cigarettes (e-cigarettes), cigars, pipes, hookah, and smokeless tobacco were collected at wave 1 (W1) (2013-2014) among youth in the nationally representative US Population Assessment of Tobacco and Health Study (12-17 years of age;

resultsThe proportion of youth who endorsed "a lot of harm" was highest for cigarettes (84.8%) and lowest for e-cigarettes (26.6%); the proportion of youth who thought products were "more harmful" than cigarettes was highest for cigars (30.6%) and lowest for e-cigarettes (5.1%). Among youth who had not used those products at W1, product-specific new use at W2 ranged from 9.1% (e-cigarettes) to 0.6% (pipes). Youth who believed that noncombustible tobacco products posed "no or little harm" at W1 were more likely to have tried those products at W2 (

conclusionsLow harm perceptions of noncigarette tobacco products predict new use of these products by youth within the next year. Targeting product-specific harm perceptions may prevent new tobacco use among youth.

Indexed as

Risk AssessmentAdolescentChildElectronic Nicotine Delivery SystemsFemaleFollow-Up StudiesHumansMalePerceptionPrevalenceRetrospective StudiesSmokingTobacco ProductsTobacco UseUnited States

Identifiers

PMID30397167
PMCPMC6317771
OpenAlexW2899848648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.